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Introduction

History of OneWorld Community Health Centers, Inc.
OneWorld Community Health Centers, Inc. is a Federally Qualified Health Center
(FQHC) in South Omaha that provides affordable health care to the Omaha area’s
vulnerable and underserved populations (One World, 2016). To better understand how
this health center functions, it is important to consider the history of South Omaha.
Specifically, there are two major events which began to attract immigrants to the South
Omaha area. The first major event came after the passage of the Pacific Railroad Act in
1862 (Dillon, Burger & Shortridge, 2007). This act established Omaha as the eastern
terminus of the transcontinental railroad. The second major event was the development
of the Omaha Stockyards and associated meat-packing industries which opened along
the railroads in the 1870s and 1880s (Dillon, Burger & Shortridge, 2007). Both events
created more demand for immigrant labor and resulted in South Omaha being resettled
by people from Mexico and other Latin American countries. In 1955, Omaha surpassed
Chicago and Kansas City and became the largest livestock market and meatpacking
center in the nation (Dillon, Burger & Shortridge, 2007). However, in the late 1960s
many of Omaha’s major meatpacking plants began to move to more rural parts of
Nebraska, and this had a significant impact on the Latino and Native American
communities. These communities were financially dependent through employment on
the meatpacking industry and therefore when it became inaccessible to them they were
faced with reduced income and consequent difficulties of having access to health care.
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In response to this need, various organizations in the Omaha area collaborated
and established the Indian-Chicano Health Center in 1970 (OneWorld, 2016). Initially
this clinic was staffed by volunteer physicians and students and provided dental and
medical services in the evenings. Slowly the clinic began to grow and expanded the
types of services being offered. In 2001, the Indian-Chicano Health Center received its
designation as a Federally Qualified Health Center (FQHC) and in 2003 it was renamed
to OneWorld Community Health Centers, Inc. In 2005, OneWorld moved its
headquarters to Omaha’s historic Livestock Exchange Building, where it all started back
in the 1960s.

Mission and patient population of OneWorld Community Health Centers, Inc.
The mission of OneWorld Community Health Centers, Inc. is to provide quality
health care with respect to diverse cultures and attend to the needs of the underserved
(One World, 2016). In 2016, One World cared for 37,771 patients, with 73.0 % of these
patients being of Hispanic or Latino origin (Health Resources & Services Administration
[HRSA], 2016). More than 60.7 % of patients seen at OneWorld are at or below 100 %
poverty line and 49 % are uninsured. From the patients that are uninsured it is
estimated that 28.2 % are children (age 0-17 years). Patients visiting OneWorld have
access and utilize many services including adult medicine, behavioral health, dental,
pediatrics, pharmacy, prenatal, quick sick urgent care, and women’s health (OneWorld,
2016).

Latino communities in the United States and Nebraska
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In 2014, the U.S. Census Bureau estimated that there were approximately 55.4
million Latinos living in the United States, comprising 17.4 % of the total US population
(Siegel et al., 2015). These estimates make the Latino population the largest
racial/ethnic minority group in the United States. Nebraska is no exception to this
statistic, and the Latino population size is estimated at 167,000 which represents a 70
% increase in population size from 2000 to 2010 (Ramos et al., 2013). The term
Hispanic or Latino has been extensively used to describe any person that is of Mexican,
Cuban, Puerto Rican, South or Central American, Dominican, or other Spanish descent
(Ennis, Rios-Vargas, & Albert, 2011). In Nebraska it is estimated that 75 % of Latinos
are of Mexican origin followed by Latinos from Central America and South America
(Ramos et al., 2013). As the Latino population continues to increase in population size,
it will be important to address the disproportionate burden of disease and death that
this population group experiences.

Health literacy among Latinos
The CDC defines health literacy as the degree to which individuals can obtain,
process, and understand basic health information and services needed to make
appropriate health decisions (CDC, 2016). The National Center for Educational Statistics
(NCES) assessed health literacy in more than 19,000 adults in the U.S. by delivering the
National Assessment of Adult Literacy (NAAL). In their final report they found that
Hispanic adults had lower average health literacy than adults in any other racial/ethnic
group (Kutner, Greenburg, Jin, & Paulsen, 2006). On a health literacy scale from 0 to
500, Whites had the highest average health literacy score at 256 while Hispanics had

Gonzales

4

the lowest average health literacy score at 197 (Kutner et al., 2006). This may be due
to difficulties in getting access to health information and being able to process it due to
cultural and language barriers.

Burden of Colorectal cancer in the United States and Nebraska
CRC ranks as the third most commonly diagnosed cancer in both men and
women (Alteri, Kramer, & Simpson, 2014; Siegel, DeSantis, & Jemal, 2014).
Approximately 4.6% of men (1 in 22) and 4.2% of women (1 in 24) will be diagnosed
with CRC in their lifetime (Siegel, Miller, & Jemal, 2016). The American Cancer Society
(ACS) estimates that in 2017 there will be 95,520 new cases of colon cancer and 39,910
new cases of rectal cancer diagnosed in the United States (ACS, 2017). Most of these
cases will develop among older individuals given that the median age for colon cancer
diagnosis is 68 in men and 72 in women (ACS, 2017). Additionally, the median age for
rectal cancer diagnosis is 63 in both men and women (ACS, 2017).
According to a 2012 Morbidity and Mortality Weekly Report (MMWR), it is
estimated that 65% of U.S. adults aged fifty years of age or older were up-to-date with
CRC screening. However, the screening rates in Nebraska were 60.9 % which is much
lower than the national average. Furthermore, from 2004 to 2008 the colorectal cancer
incidence rate was 65.4 per 100,000 for Nebraska males and 47.0 per 100,000 for
Nebraska females (Nebraska Department of Health and Human Services [NDHHS],
2011). The Nebraska incidence rates were higher than the US rate of 55.7 per 100,000
for males and 41.4 per 100,000 for females (NDHHS, 2011). During this same time
period the colorectal cancer mortality rate was 22.9 per 100,000 for Nebraska males
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and 15.6 per 100,000 for Nebraska females (NDHHS, 2011). The mortality rate was also
higher for Nebraska compared to the 21.2 per 100,000 for males and 14.9 per 100,000
for females (NDHHS, 2011). Furthermore, during the period of 2010 to 2014 there was
an estimated 4,550 Nebraska residents who were diagnosed with colorectal cancer
while 1,714 Nebraska residents died due to colorectal cancer and associated
complications (NDHHS, 2017). For Nebraska residents, it is estimated that at time of
diagnosis 3 percent of cases were in situ, 38 % were local, 35 % were regional, 17 %
were distant, and 7 % were unstaged (NDHHS, 2017).
It is estimated that 27,150 men and 23,110 women will die from colorectal
cancer in 2017 (ACS, 2017). However, racial and ethnic minorities are more likely to
develop and die from cancer when compared to the general population. In 2015, it was
reported that 22 % of deaths were due to cancer and 20% of deaths were due to heart
disease for Latinos (Barrera et al., 2015). For non-Latino whites, it was reported that 24
% of deaths were due to heart disease and 23 % of deaths were due to cancer
(Barrera et al., 2015). This population is being affected by a cancer health disparity,
defined by the National Cancer Institute (NCI) as ‘adverse differences in cancer
incidence, cancer prevalence, cancer mortality, cancer survivorship, and burden of
cancer or related health conditions that exist among specific population groups in the
United States’ (NCI, 2008). In Nebraska, the top five causes of death for Latinos are
cancer (18.6%), heart disease (14.9%), unintentional injury (13.9%), diabetes (4.6%),
and stroke (4.6%) (Ramos, 2013). Among these cancers, CRC is the second-leading
cause of cancer deaths for Latinos in the United States when males and females are
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combined (National Colorectal Cancer Roundtable [NCCRT], 2016) One factor that may
be contributing to CRC deaths is the low rates of CRC screening, which have been
shown to decrease incidence, improve survival and mortality (Lai et al., 2016; Mandel et
al., 1993; Sineshaw, Robbins & Jemal, 2014).

Screening tests for colorectal cancer
There are two main categories for screening tests that can be used to detect
colorectal cancer. The first category consists of tests that can find both colorectal
polyps and cancer, such as a colonoscopy. While the second category of tests are those
that mainly find cancer, such as fecal occult blood test (FOBT) and fecal
immunochemical test (FIT). FOBT and FIT have low to moderate sensitivity, however,
these tests are low cost, can be performed at home, and are noninvasive. Furthermore,
large randomized controlled trials have demonstrated that these two CRC screening
tests can decrease CRC mortality by up to 33 % (Shaukat et al., 2013; Levin & Corley,
2013; Mandel et al., 1993; Hardcastle et al., 1996; Kronborg O et al., 1996). Some
limitations of these two screening tests are that they need to be repeated on an annual
basis, FOBT requires dietary restrictions, FIT vary in sensitivity and specificity, both test
will miss most polyps, and both can produce false-positive test results (ACS, 2017).
Colonoscopies have high sensitivity and specificity, can examine the entire colon, are
performed once every ten years, and allow for biopsy and removal of polyps (ACS,
2017). Additionally, the National Polyp Study provided evidence for the long-term
effectiveness of a colonoscopy. In this study it was discovered that patients who
removed adenomas through colonoscopy had a 53 % reduction in mortality from colon
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cancer over a median of 15.8 years (Zauber, 2012). However, some limitations of a
colonoscopy are that it requires an orally administered bowel preparation, can be
expensive, patients may see a colonoscopy as an invasive procedure (Young &
Womeldorph, 2013), and it requires a minimum of two days.
In 2005, the CDC initiated the Colorectal Cancer Screening Demonstration
Program (CRCSDP) to explore the feasibility of establishing a national CRC screening
program for underserved populations. One of the selected sites was the Nebraska
Department of Health and Human Services (NDHHS). In Nebraska, the selected primary
screening test was FOBT for individuals at average risk and colonoscopy for individuals
for above-average risk (Tangka, Subramanian, Beebe, Hoover, Royalty, & Seeff, 2013).
This program found that the average clinical cost per patient was $49 for FOBT
(including costs for screening, diagnosis, initial surveillance, office visits, and associated
clinical services) while the average clinical cost per patient was $842 for colonoscopy
(including costs for screening, diagnosis, initial surveillance, office visits, and associated
clinical services) (Tangka et al., 2016). In comparison, a study by Lang et al. (2009),
provided detailed estimates of lifetime and phase-specific CRC treatment costs. This
study, which included 56,838 CRC patients, found that the lifetime cancer-related health
care costs per year of survival varied by stage of colorectal cancer (Lang et al., 2009).
Patients with stage 0 CRC spent an excess of $3,210 per year, stage I patients spent an
excess of $4,238 per year, stage II patients spent $6,723 per year, stage III patients
spent an excess of $10,516 per year, and finally stage IV patients spent an excess of
$30,794 per year (Lang et al., 2009). The excess costs associated with the treatment
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and management of CRC highlight the importance of interventions aimed at the
prevention and early detection of CRC.

Knowledge and awareness of colorectal cancer and screening
Using data from the National Health Interview Survey, a study found that in 2010
the CRC screening was 58.6%, below the Healthy People 2020 target of 70.5%
(Joseph, King, Miller, Richardson, & CDC, 2012). Multiple studies have examined
knowledge of cancer among Latino women, and have found that Latino women have
the lowest knowledge of cancer screening guidelines and lowest screening rates of any
ethnic group (Borders, Warner, & Sutkin, 2003; Ramirez et al., 2000; Suarez et al.,
1994). Similarly, a study by Coronado and Thompson (2000), found that Latino men
were more likely to have limited knowledge about the causes of cancer and the need
for prevention practices than their non-Latino counterparts.

Perception and attitudes on colorectal cancer and screening
The ACS explored perceptions about CRC and screening through focus groups.
Some perceptions included that Latinos are less likely to follow physician’s
recommendations if there is a lack of trust, view cancer screening logistics as a barrier,
view cancer as a strong source of fear, and have minimal awareness and knowledge
about CRC and screening tests (ACS, 2017). Additionally, a study by Walsh et al.,
(2004), found that Latinos have misperceptions and erroneous understandings of CRC
and screening. Specifically, Latinos were more likely to find FOBT embarrassing and
that Latinos did not see the need to get screened if they were feeling healthy, when

Gonzales

9

compared to non-Hispanic whites (Walsh et al., 2004). An additional study also
identified that embarrassment was a factor that was preventing Latinos from
undergoing colorectal cancer screening (Fernandez et al., 2008). Another mentioned
potential cause of colorectal cancer was the consumption of “bad food” (Goldman, Diaz,
& Kim, 2009). Some participants mentioned that foods high in fat or hot spices can
increase the potential in colorectal cancer (Goldman, Diaz, & Kim, 2009). Lastly,
various studies indicated that unscreened Latino patients mentioned that they had not
undergone screening because it has never been mentioned or suggested to them by
medical or public health professionals (Cameron et al., 2007).

Barriers on colorectal cancer screening
The ACS has identified many barriers on CRC screening. The first barrier is that
Latinos view cancer screening logistics as a barrier (Green et al., 2008; Fernandez et
al., 2008; Percac-Lima et al., 2009; Walsh et al., 2004). For example, participants in the
ACS focus group mentioned that they tend to procrastinate or miss their appointments
because the importance of screening is not understood. A second barrier is that Latinos
view cancer as a strong source of fear (Fernandez et al., 2008; Goodman et al., 2006;
Jandorf et al., 2010). Participants mentioned that there is a fear of the procedure, the
preparation process, and the pain that is associated with some CRC screening
procedures. A third barrier is affordability, and it has been noted that many Latinos
have a low income or lack health insurance (Fernandez et al., 2008; Goodman et al.,
2006). A fourth barrier is machismo or considering CRC as embarrassing, and this can
dictate whether Latinos are willing to engage in a CRC screening procedure (Walsh et
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al., 2004; Goodman et al., 2006). The fifth barrier that has been identified by the ACS
relates to limited knowledge that CRC screening can prevent CRC (Walsh et al., 2004;
Fernandez et al., 2008; Goodman et al., 2006). The final major barrier is that doctors
are not explaining the need for screening effectively, and this may be due to lack of
connection with the patients, doctors’ underestimation of health literacy-related
barriers, or doctors’ lack of emphasis on the importance of CRC screening (Walsh et al.,
2004; Fernandez et al., 2008; Jandorff et al., 2010).
Significance of assessing awareness and attitudes of the Latino community in
Omaha on CRC and screening
Currently, OneWorld primarily utilizes fecal occult blood tests (FOBTs) and
colonoscopies to detect early colorectal cancer in the early stages or the presence of
any polyps. However, a qualitative study showed that patients with low health literacy
had poor knowledge of CRC and screening terminology terms such as “FOBT,”
“colonoscopy,” and “polyp”, which may negatively impact colorectal cancer screening
rates for these patients (Davis et al., 2001). This is especially true for Federally
Qualified Health Centers (FQHCs) who have reported low CRC screening rates.
Nationally, it was reported that the CRC screening rates at FQHCs were 34.5% in 2014,
38.3% in 2015, and 39.9% in 2016 (NCCRT, 2017). OneWorld has higher than average
CRC screening rates which were 40.2 % in 2014, 46.2 % in 2015, and 47.4 % in 2016
(HRSA, 2016). These low levels of knowledge and screening are concerning, and
multiple studies have reported that Latinos are more likely to be diagnosed with CRC at
a later stage (Vidal et al., 2009; Howe et al., 2006; ACS, 2007). The 5-year survival rate
for Latinos decreases from 90.1% when diagnosed at a localized state, to 69.2% when
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diagnosed at a regional stage, and 11.7% when diagnosed at a distant stage (Siegel et
al., 2012).
Conceptual framework
The conceptual framework that is guiding this study is summarized in Figure 1.
This is the same conceptual framework that was utilized by Partin et al. (2010) and it
draws insight from the Health Belief Model (HBM), the Theory of Planned Behavior
(TPB), and the Social Cognitive Theory (SCT). Through the combination of these three
theories we are assuming that screening adherence is determined by background
factors such as demographics and health characteristics; environmental factors such as
social influence and physician recommendation for screening; and cognitive factors such
as beliefs about outcomes associated with CRC screening, perceptions about one’s
ability to undergo CRC screening, and knowledge of screening and importance.
Screening adherence can directly be influenced by environmental factors and cognitive
factors. Finally, background factors can indirectly influence adherence through their
association with environmental and cognitive factors. This study focuses on the
cognitive factors influencing screening with the hope that future interventions can be
developed based on the results to improve CRC screening among the Latino community
in Omaha.
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Methods:

Research Question
This work addresses the current knowledge, awareness, perception, attitudes,
and barriers to colorectal cancer screening among the Latino population receiving
health services at the One World Community Health Center in South Omaha, Nebraska .

Study Design
This was a cross-sectional study. It was conducted between June 2017 – October
2017 at the OneWorld Community Health Centers in South Omaha, Nebraska.
OneWorld in South Omaha is a federally qualified health center (FQHC) that serves a
predominantly Hispanic/Latino community. All study procedures were approved by the
University of Nebraska Medical Center Institutional Review Board (IRB # 303-17-EX).

Eligibility Criteria
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There were two eligibility criteria that a participant had to meet in order to be
eligible for this study: (1) Be at least 30 years of age and (2) be of Hispanic or Latino
origin (Mexican, Mexican-American, Puerto Rican, Cuban, Central American, South
American, and of other Latino, Hispanic, or Spanish origin).

Study Population
The study population for this project included 150 individuals over 30 years of
age that are of Latino or Hispanic descent receiving health services at the One World
Community Health Center in South Omaha, Nebraska. This sample size was calculated
based on a 2005 study that found that 1.1% of the general population indicated that
they had a “very high chance” of developing colon cancer in the future (Cantor et al.,
2005). We assumed a similar proportion for the Latino community in South Omaha and
found that a sample size of 300 produced a two-sided 95% confidence interval (CI)
with a width equal to 0.028 when the sample proportion is 0.011. However, due to the
difficulty of recruiting participants in this study and the limited amount of time we
decided that a sample size of 150 would be sufficient. Samples of 150 produce a twosided 95% CI with a width equal to 0.043.

Assessment tool
A structured survey was developed consisting of 60 questions to collect
information about colorectal cancer and colorectal cancer screening among
Hispanics/Latinos in Omaha. This survey included validated questions about
demographics, medical history, knowledge and awareness on colorectal cancer and
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screening tests, perceptions and attitudes on colorectal cancer and screening tests, and
barriers on colorectal cancer screening. Questions regarding demographics and medical
history were retrieved from the 2016 Behavioral Risk Factor Surveillance System
Questionnaire (BRFSS) (Centers for Disease Control and Prevention [CDC], 2015).
Questions regarding knowledge and awareness on colorectal cancer and screening
tests, perceptions and attitudes on colorectal cancer and screening tests, and barriers
on colorectal cancer screening were retrieved from a national patient survey of
colorectal cancer screening behavior known as the Survey of Colorectal Cancer
Educational and Environmental Needs (SCREEN). This survey has been used in a
previous research study by Partin et al. (2010), and different sections of this survey
have been evaluated by other researchers. The survey was developed in English and
then translated into Spanish by a University of Nebraska Medical Center College of
Public Health faculty member fluent in this language. Following the translation of the
survey into Spanish, the survey was then back-translated into English by a graduate
student from the University of Nebraska at Omaha. These steps were taken to
accommodate to the needs of the participants and to ensure validity of the translation.

Barriers on colorectal cancer and screening
In total there were 26 questions regarding barriers on CRC and screening. These
questions were asked through a five-point version of the Likert Scale, which allowed
respondents to indicate if they Strongly Agree, Agree, Neither Agree nor Disagree,
Disagree, or Strongly Disagree with a question. We scored the five-point Likert Scale by
assigning a value of 5 for Strongly Agree, a value of 4 for Agree, a value of 3 for
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Neither Agree nor Disagree, a value of 2 for Disagree, and a value of 1 for Strongly
disagree. Due to the format of these questions there were four questions that were
reverse coded for the analyses. From these 26 questions only 25 were utilized in the
analyses. The 25 questions were grouped into the two different types of factors:
cognitive factors or environmental factors as seen in Figure 2. To further divide these
factors, we created six different categories for cognitive factors and the environmental
factor remained with one category.
Fig 2. Layout of questions regarding barriers on colorectal cancer and screening

Figure 3 reports the different questions that are found in the six different
categories for cognitive factors and the one category for environmental factor. We
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defined the categories of cognitive factors and the category of environmental factor as
it has been previously defined by Vernon, Myers, and Tilley (1997). In their study they
utilized the following definitions: Salience and coherence: perceptions about the
technical effectiveness, practical convenience, personal benefit, and whether the
behavior is actively encouraged by significant others. Perceived Susceptibility:
subjective personal risk of developing colorectal cancer or polyps. Worries and Fears:
perceived negative components of consequences of undertaking and completing the
behavior. Efficacy of Screening: perceived positive components or consequences of
undertaking and completing the behavior. Self-efficacy: an individual’s belief in their
capacity to execute a behavior and Social Influence: role of social norms and interaction
with members of one’s social network (Vernon et al., 1997). Knowledge was defined as
the familiarity with CRC screening principles and screening guidelines (Vernon et al.,
1997).
Fig 3. Questions included in the cognitive factors and environmental factors affecting colorectal cancer and screening

Cognitive
factors
Salience

Fears

Susceptibility

Screening efficacy

Questions
1. Doing colon cancer makes sense to me.
2. I think the benefits of colon cancer testing outweigh any difficulty I might have
in going through the test.
3. Going through colon cancer testing is an important thing for me to do.
4. I believe that having colon cancer testing can help to protect my health.
1. I am afraid of having an abnormal test result. ⱡ
2. I am worried that testing will show that I have colon cancer. ⱡ
3. I am bothered by the possibility that testing might be physically uncomfortable. ⱡ
1. I believe the chance I might develop colon cancer is high.
2. I think it is very likely that I will develop colon cancer.
3. I believe that the chance that I will develop polyps is high.
4. I think that compared to other persons my age, I am at lower risk for colon cancer.
1. I think that when colon polyps are found and removed, colon cancer can be
prevented.
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2. I believe that when colon cancer is found early, it can be cured.
1. Arranging my schedule to go through colon cancer testing is an easy thing to do.
2. Finding time to go through colon cancer testing would be difficult for me to do.
3. Going through colon cancer testing would be difficult for me to do. ⱡ
4. I think that going through colon cancer testing would be an easy thing for me to do.
1. I believe that colon cancer is mainly a problem for men.
2. I believe that a person could have colon cancer but not have any symptoms.
3. I think that getting checked regularly for colon cancer increases the chances of finding
cancer when it’s easy to treat.
Questions

1. I want to do what members of my immediate family think I should do about colon
cancer testing.
2. Members of my immediate family think I should go through colon cancer testing.
3. My doctor or health professional thinks I should have colon cancer testing.
4. I want to do what my doctor or health professional thinks I should do about colon
cancer testing.
ⱡ indicates question was reverse coded when calculating the mean

Participant Recruitment
OneWorld patients were recruited by setting up a table in the main lobby of the
OneWorld Community Health Centers Livestock Exchange Building. Interested
individuals that met the inclusion criteria were eligible to complete the survey. The
paper-based survey was delivered to each participant by a face-to-face interview, and
each question was read verbatim. Surveys were completed in either English or Spanish
based on the participants preferred language. After an individual had successfully
completed a survey they were given a five-dollar gift card as a sign of appreciation for
the participants’ time to fill out the survey.

Data analysis
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Data was transferred from questionnaires to an Excel file. SAS 9.4 was used to
analyze the data. Descriptive analysis of the data included frequency and percentages
for categorical variables and means and standard deviations for continuous variables.
Comparisons of survey results by demographic variables were performed (e.g. gender
or age). Associations were examined between questions pertaining to demographics,
medical history, knowledge and awareness, perceptions and attitudes, and barriers.
Specifically, we examined if there are any factors that increase or decrease knowledge
and awareness, affect awareness and attitudes, or contribute to barriers to colorectal
cancer screening. This study included the use of Kruskal-Wallis test, Mann-Whitney test,
and Chi-square tests. A Kruskal-Wallis test was used to determine if there were any
statistically significant differences between two or more groups regarding barriers to
colorectal cancer and colorectal cancer screening. The Mann-Whitney test was used as
an alternative to the t-test, specifically when the variable in question is not normally
distributed in the two or more groups. A Chi-square was used to examine any type of
relationship between two or more categorical variables. The Fisher’s exact test was
used as an alternative to the Chi-square test when one or more of the categorical
variables have a small expected frequency. A significance level of 0.05 was used for all
statistical tests.
Results

Demographics
The demographic information of study participants is summarized in Table 1. In
total, there were 150 eligible subjects who responded to the survey. The mean age of
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participants was 44.5 years old with a minimum age of 30 years old and a maximum
age of 79 years old. When participants were divided into three categories, according to
age groups, there were 65 (43.3%) individuals in the 30-39 age group, 39 (26.0%) in
the 40-49 age group, and 46 (30.7%) in the ≥ 50 age group. More than 50 % of
participants were females, and 82 % identified as being Mexican, Mexican-American, or
Chicano. More than 70 % of participants were married or were part of an unmarried
couple. When looking at the education level of participants, one-third reported having
an elementary school education and one-third reported having a high school education.
Interestingly, only 13 % of the study population reported having an education level
higher than high school. More than 74 % of participants indicated that their household
income is less than twenty-five thousand dollars.
Table 1. Demographic characteristics of study sample
Characteristics
Age (years)
30-39
40-49
≥50
Gender
Male
Female
Hispanic/Latino origin

n (%)

Mexican, Mexican-American, or Chicano
Central American
Other Latino, Hispanic, or Spanish origin
Marital status
Married or unmarried couple
Divorced, separated, widowed, never married
Education (years)
None
1-6
7-8

123(82.0)
26(17.3)
1(0.7)

65(43.3)
39(26.0)
46 (30.7)
70(46.7)
80(53.3)

107(71.8)
42(28.2)
3(2.0)
50(33.3)
34(22.7)
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9-12
>12
Income
<15,000
15,000-24,999
≥25,000

50(33.3)
13(8.7)
58 (38.9)
53 (35.6)
38 (25.5)

Medical history
The medical history of study participants is summarized in Table 2. Most
participants indicated that their health status is good (36.0%) or fair (44.7%).
Additionally, more than 67 % of participants reported not having any type of insurance
to cover medical costs and only 36.7 % of participants had access to at least one
personal doctor or health care provider at the time of the study. The cost associated
with going to a primary care provider was identified as being an issue for 53 out of the
150 study participants. Interestingly, more than 69 % of participants indicated that
their last routine checkup with a doctor was within the past year. More than 69 % of
participants indicated that within the last twelve months they have gone to a doctor,
nurse, or other health professional to get care for themselves at least one time.
For questions regarding colorectal cancer, only 2.7 % of participants indicated
that they had been diagnosed with colorectal cancer or polyps. Furthermore, 5.3 % of
participants stated that they had received a diagnosis of an inflammatory bowel disease
such as Crohn’s disease or ulcerative colitis. Lastly, only 7.3 % of individuals marked
that they had family history of colorectal cancer or polyps.
Table 2. Medical history of study sample

Characteristics
Health status

n (%)
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Excellent
Very good
Good
Fair
Poor
Insurance
Yes
No
Access to a personal doctor
Yes, only one
More than one
No
Could not go to doctor due to cost
Yes
No
Do not know/Not sure
Last routine check-up
Never
< 1 year
between 1 and 2 years
between 2 and 5 years
> 5 years
Number of provider visits in previous year
0
1
2-4
≥5
Been diagnosed with colorectal cancer or polyps
Yes
No
Do not know/Not sure
Been diagnosed with an inflammatory intestinal disease
Yes
No
Do not know/Not sure
Family history of colorectal cancer
Yes
No
Do not know/Not sure

8(5.3)
11(7.3)
54(36.0)
67(44.7)
10(6.7)
49(32.7)
101(67.3)
45(30.0)
10(6.7)
95(63.3)
53(35.3)
96(64.0)
1(0.7)
12(6.7)
103(69.1)
11(7.4)
11(7.4)
12(8.1)
46(30.9)
25(16.8)
63(42.3)
15(10.1)
4(2.7)
145(96.7)
1(0.7)
8(5.3)
139(92.7)
3(2.0)
11(7.3)
137(91.3)
2(1.3)

Knowledge and understanding
The knowledge and understanding of colorectal cancer and associated screening
tests is summarized in Table 3. Twenty-six percent of participants reported that they
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had heard of a FOBT, while more than 53 % of participants indicated that they had
heard of a colonoscopy. Approximately, 85 % of participants responded that a doctor
has not advised them to do a FOBT and 80 % noted that a doctor has not advised them
to undergo a colonoscopy. Only 12 % of participants have done a FOBT and 12.7 %
have undergone a colonoscopy. Overall, most participants prefer undergoing a FOBT
(52%) when compared to a colonoscopy (32.7%) or other type of test (8%).
Interestingly, only 2 participants responded that they would prefer to not be tested for
colorectal cancer.

Table 3. Knowledge and understanding of colorectal cancer and
colorectal cancer screening tests

Characteristics
Heard of FOBT
Yes
No
Do not know/Not sure
Has a doctor advised you to undergo an FOBT
Yes
No
Do not know/Not sure
Have you undergone an FOBT
Yes
No
Do not know/Not sure
Heard of a colonoscopy
Yes
No
Has a doctor advised you to undergo a colonoscopy
Yes
No
Have you undergone a colonoscopy
Yes
No
Do not know/Not sure
Test preference
FOBT

n (%)
39(26.0)
109(72.7)
2(1.3)
21(14.0)
127(84.7)
2(1.3)
18(12.0)
130(86.7)
2(1.3)
80(53.3)
70(46.7)
30(20.0)
120(80.0)
19(12.7)
130(86.7)
1(0.7)
78(52.0)
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Colonoscopy
A different test
Do not want to be tested
Do not know/Not sure

49(32.7)
12(8.0)
2(1.3)
9(6.0)

We conducted a set of analyses to compare individuals that were below 50 years
of age with those that were over 50 years of age, which is the screening age, and that
did not report family history of CRC. Individuals that have reported family history of
CRC would have been screened earlier, and for this reason they were excluded. In total
we had 137 participants included in this analysis which is summarized in Table 4. One
finding was that younger participants were less likely to have heard about FOBT and
significantly less likely to have heard of colonoscopy (p = .0015) compared to older
participants. People that were 50 years or older were significantly more likely to have
had FOBT (p < .0001) and/or a colonoscopy (p < .0001) when compared to those that
were 49 years or younger. Also, individuals 50 or older were significantly more likely to
have been advised by a doctor to undergo an FOBT (9.5% vs 2.9%) (p < .0001) or a
colonoscopy (13.9% vs 3.6%) (p < .0001) compared to individuals 30 to 49 years of
age.
Table 4. Knowledge and understanding of colorectal cancer screening tests for participants 30
to 49 years vs participants 50 years or older
Characteristics
Age group ⱡ
30 to 49 (n = 137) 50 or older (n = 137)
p-values
FOBT
Heard of FOBT
Ever had FOBT*
Doctor advise FOBT*
Colonoscopy
Heard of
colonoscopy*

n(%)
21(21.6)

n(%)
13(32.5)

0.1813

3(3.1)
4(2.9)

11(27.5)
13(9.5)

< 0.0001
< 0.0001

39(40.2)

28(70.0)

0.0015
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Ever had
colonoscopy*
Doctor advise*
colonoscopy

4(4.1)

11(27.5)

< 0.0001

5(3.6)

19(13.9)

< 0.0001

ⱡ Participants with a family history of colorectal cancer were excluded
from both age groups
* Differences between groups are statistically significant at the p <
0.05 level using Chi-square test

Cognitive and environmental factors influencing colorectal cancer screening
Percentages were calculated for cognitive factors and environmental factors
regarding colorectal cancer and colorectal cancer screening tests. With regards to
cognitive factors, only 14.9 % of participants were able to correctly state the screening
initiation age for colorectal cancer (50 years old). Furthermore, there were differences
when participants were asked how often people should do FOBT and how often people
should do colonoscopies. More than 80 percent of the study population correctly stated
that FOBT should be done on a yearly basis while only 10.7 percent correctly stated
that a colonoscopy should be done once every ten years. We expanded upon these
findings and compared knowledge of colorectal cancer guidelines according to age
groups. Participants that were 50 or older were more likely to correctly guess how often
to do FOBT and colonoscopy than participants that were 30 to 49 years old, but the
differences were not significant. We were able to find significant differences (p = .0377)
regarding the screening initiation age, and older individuals correctly guessed the
screening initiation age 23.9 % of the time compared to younger individuals that
correctly guessed the screening initiation age 10.8% of the time.
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Table 5. Knowledge of colorectal cancer guidelines and comparisons by age
groupsquestion
Knowledge
30 or older (n = 149) ⱡ
Correct
n(%)
22 (14.9)
120 (80.5)
16 (10.7)

Screening initiation age
How often to do FOBT
How often to do colonoscopy
Knowledge question

Incorrect
n(%)
126 (85.1)
29(19.5)
134 (89.3)

Screening initiation age

30 to 49 (n = 104) ⱡ
Correct
Incorrect
n(%)
n(%)
11 (10.8) 91 (89.2)

Age groups
50 or older (n = 46) ⱡ
Correct
Incorrect
n(%)
n(%)
11 (23.9)

How often to do FOBT

80 (77.7)

40 (87.0)

6 (13.0)

0.1859

7 (15.2)

39 (84.8)

0.2298

How often to do colonoscopy

9 (8.7)

23
(22.3)
95 (91.3)

p-values
0.0377

* Differences between groups are statistically significant at the p < 0.05 level using
Chi-square test

ⱡ Numbers may not add up due to participants not answering a question
Percentages were calculated for cognitive factors and environmental factors
regarding colorectal cancer and colorectal cancer screening tests as reported in Table 6.
In the table we only included the percent of participants that indicated that they
‘Agreed’ or ‘Strongly Agreed’ with the different statements for cognitive and
environmental factors. All questions included in salience had more than 93 % of
respondents indicating that they agreed with the statements. For the questions
regarding fears, the percentage of participants that agreed with this statement varied
from 27.3 % to 40 %. Susceptibility had more than 42 percent of participants in
agreement with two questions and more than 70 % in agreement with the other two
questions. For susceptibility the question that had the most people indicate that they
‘Agree’ or ‘Strongly Agree’ was ‘I believe the chance I might develop colon cancer is
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high’ with 71.3 %. Both questions in the screening efficacy category had more than 90
% of participants that agreed with the statements. Self-efficacy had consisted of two
questions that had more than 83 % agreement, one question with 30 % agreement,
and one question with 43.3 % agreement. For knowledge more than 89 % of
participants ‘Agreed’ or ‘Strongly Agreed’ for two questions. However, the question in
knowledge that stated, ‘I believe that colon cancer is mainly a problem for men’ only
had 51.3 agreement. For the question under social influence, there were two questions
that had more than 86 % agreement, one question with 71.3 % agreement, and one
question with 68 % agreement.
Table 6. Percent distribution and mean scale scores for cognitive factors and environmental factors

Questions

n(%)*
147 (98.0)
140 (93.3)

Fears

Doing colon cancer testing makes sense to me.
I think the benefits of colon cancer testing outweigh any difficulty
I might have in going through the test.
Going through colon cancer testing is an important thing for me
to do.
I believe that having colon cancer testing can help to protect my
health.
I am afraid of having an abnormal test result.

41 (27.3)
60 (40.0)

Susceptibility

I am worried that testing will show that I have colon cancer.
I am bothered by the possibility that testing might be physically
uncomfortable.
I believe the chance I might develop colon cancer is high.
I think it is very likely that I will develop colon cancer.

63 (42.0)

I believe that the chance that I will develop polyps is high.

67 (44.7)

I think that compared to other persons my age, I am at lower risk
for colon cancer.
I think that when colon polyps are found and removed, colon
cancer can be prevented.
I believe that when colon cancer is found early, it can be cured.

105 (70.0)

Cognitive
factors
Salience

Screening efficacy

145 (96.7)

Mean

4.2

149 (99.3)
58 (38.7)

2.7

107 (71.3)

3.3

135 (90.0)
148 (98.7)

4.1
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Arranging my schedule to go through colon cancer testing is an
easy thing to do.
Finding time to go through colon cancer testing would be difficult
for me to do.
Going through colon cancer testing would be difficult for me to
do.
I think that going through colon cancer testing would be an easy
thing for me to do.
I believe that colon cancer is mainly a problem for men.

138 (92.0)

I believe that a person could have colon cancer but not have any
symptoms.
I think that getting checked regularly for colon cancer increases
the chances of finding cancer when it’s easy to treat.

134 (89.9)

65 (43.3)
45 (30.0)

3.5

124 (83.2)
77 (51.3)

3.7

140 (94.0)

Questions
I want to do what members of my immediate family think I should
do about colon cancer testing.

130 (86.7)

Members of my immediate family think I should go through colon 107 (71.3)
cancer testing.
My doctor or health professional thinks I should have colon
102 (68.0)
cancer testing.
I want to do what my doctor or health professional thinks I should 138 (92.0)
do about colon cancer testing.
* Combining participants that selected Agree or Strongly Agree on a 5-point Likert Scale: 1 = strongly disagree, 2 =
disagree, 3 = neither agree nor disagree 4 = agree, 5 = strongly agree

After calculating percentages, we calculated an overall mean score for salience,
fears, susceptibility, screening efficacy, self-efficacy, knowledge, and social influence.
With respect to cognitive factors, the mean for salience was 4.2, mean for fear was 2.7,
mean for susceptibility was 3.3, mean for screening efficacy was 4.1, mean for selfefficacy was 3.5, and mean for knowledge was 3.7. The mean score for social influence
was 3.8. The cognitive factors and environmental factors were further studied in the
context of three different independent variables. The three independent variables were
age group, gender, and education level. These comparisons are summarized in Table 7.

3.8
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When cognitive and environmental factors were investigated in the context of age
group there were no significant differences in the mean score between the groups for
salience, fears, susceptibility, screening efficacy, self-efficacy, or knowledge. However,
a significant difference was found between the factor of social influence and age group
(p = .0105). The mean score for individuals in the 30 to 39 age group was 3.6 (SD =
0.6), the mean score for individuals in the 40 to 49 age group was 3.7 (SD = 0.5), and
the mean score for individuals in the 50 or older age group was 4.0 (SD = 0.4). These
differences were further explored according to the questions that made up the
environmental factor of social influence. These findings are summarized in Figure 4.
Percentages for ‘Agree’ and ‘Strongly Agree’ were combined and displayed on the left
side of the graph. Percentages for ‘Disagree’ and ‘Strongly Disagree’ were also
combined and displayed on the right side of the graph. There were significant
differences among the three age groups for the statement ‘Members of my immediate
family think I should go through colon cancer testing (p = .0039).’ Eighty-seven percent
of individuals 50 years or older agreed with this statement compared to 66.7 percent of
individuals 40 to 49 years of age and 63.1 percent of individuals 30 to 39 years of age.
There were also significant differences (p = .0123) for the statement ‘My doctor or
health professional thinks I should have colon cancer testing.’ Older individuals were
more likely to agree with this statement compared to younger individuals.
With respect to gender there were no significant differences between males and
females for the cognitive factors salience, fears, susceptibility, screening efficacy, or
self-efficacy. Furthermore, there was also no significant difference for the
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environmental factor of social influence. However, for the cognitive factor of knowledge
there were significant differences (p = .0492) among the two gender groups. The mean
score for males was 3.8 (SD = 0.5) and the mean score for females was 3.6 (SD = 0.6).
These differences for the cognitive factor of knowledge between genders were further
explored, and the findings are reported in Figure 5. Percentages for ‘Agree’ and
‘Strongly Agree’ were combined and displayed on the left side of the graph.
Percentages for ‘Disagree’ and ‘Strongly Disagree’ were also combined and displayed on
the right side of the graph. More than 65 percent of males selected the response
options of ‘Agree’ or ‘Strongly Agree’ to the question ‘I believe that colon cancer is
mainly a problem for men.’ This is significantly (p = .004) higher when compared to the
38.8 % of females who selected ‘Agree’ or ‘Strongly Agree’ for the same question.
Finally, with regards to education level there was no significant difference for the
cognitive factors of salience, fears, screening efficacy, self-efficacy, or knowledge. Also,
there was no significant difference between the three different education level groups
for the environment factor social influence. A significant difference was noted between
the three different groups for the cognitive factor of susceptibility (p = 0.0006). The
mean score for participants that had an education level of 6th grade or less was 3.6 (SD
= 0.6), an education level of 7 th to 8th grade was 3.3 (SD = 0.7), and an education level
of 9th grade or higher was 3.1 (SD = 0.6). These differences are further explored in
Figure 6. Percentages for ‘Agree’ and ‘Strongly Agree’ were combined and displayed on
the left side of the graph. Percentages for ‘Disagree’ and ‘Strongly Disagree’ were also
combined and displayed on the right side of the graph. There are three questions that
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had significant differences according to education level. For the question ‘I believe the
chance I might develop colon cancer is high’ more than 86 percent of participants with
an education level of sixth grade or below selected ‘Agree’ or ‘Strongly Agree’ compared
to 67.6 percent of participants with a seventh grade or eighth grade education level or
60.3 percent of participants with an education level of high school or above (p =
.0014). Approximately, fifty-seven percent of people with an education level of sixth
grade or below selected ‘Agree’ or ‘Strongly Agree’ to the question ‘I think it is very
likely that I will develop colon cancer’ compared to 38.2 percent of people with a
seventh or eighth grade level or 31.7 percent of people with an education level of high
school or above (p = .0104). Lastly, there were significant differences (p = .0062) for
the question ‘I believe that the chance that I will develop colon polyps is high.’ Sixty
four percent of people who had an education level of sixth grade or below agreed or
strongly agreed compared to 52.9 percent and 27 percent for people who had an
education level of seventh of eighth grade or individuals who had an education level of
high school or above, respectively. All other figures comparing cognitive factors and
environmental factors to the three variables of age group, gender, and education level
are presented in Appendix part A.

Table 7. Comparing barriers by age group, gender, and education
level
Age group ⱡ
30 to 39
Factor
Salience
Fears

40 to 49

50 or
older

mean, (std dev)
4.2 (0.4)
4.2 (0.4)
4.2 (0.4)
2.6 (0.8)

2.8 (0.8)

2.8 (0.8)

p-values
0.9367
0.4572
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Susceptibility

3.3 (0.7)

3.3 (0.7)

3.5 (0.6)

0.3104

Screening efficacy

4.1 (0.5)

4.1 (0.4)

4.1 (0.4)

0.6162

Self-efficacy

3.5 (0.4)

3.5 (0.4)

3.5 (0.4)

0.7478

Knowledge

3.8 (0.5)

3.7 (0.6)

3.6 (0.6)

0.5063

Social influence*

3.6 (0.6)

3.7 (0.5)

4.0 (0.4)

0.0105

Gender β
Male
Female
mean, (std dev)
4.2 (0.4)
4.2 (0.4)

0.5901

Fears

2.8 (0.8)

2.6 (0.8)

0.2142

Susceptibility*

3.4 (0.6)

3.2 (0.7)

0.0369

Screening efficacy

4.1 (0.4)

4.1 (0.4)

0.2777

Self-efficacy
Knowledge*

3.5 (0.4)
3.8 (0.5)

3.5 (0.4)
3.6 (0.6)

0.3239
0.0492

Social influence

3.8 (0.5)

3.6 (0.6)

0.5205

Factor
Salience

Education level ⱡ
7th – 8th
9th grade
grade
or higher
mean, (std dev)
4.2 (0.4)
4.2 (0.4)
4.2 (0.4)

0.8494

Fears

2.6 (0.8)

2.8 (0.8)

2.8 (0.8)

0.1805

Susceptibility*

3.3 (0.7)

3.3 (0.7)

3.5 (0.6)

0.0006

Screening efficacy

4.1 (0.5)

4.1 (0.4)

4.1 (0.4)

0.6829

Self-efficacy

3.5 (0.4)

3.5 (0.4)

3.5 (0.4)

0.7340

Knowledge

3.8 (0.5)

3.7 (0.6)

3.6 (0.6)

0.5496

Social influence

3.6 (0.6)

3.7 (0.5)

4.0 (0.4)

0.5067

6th grade
or less
Factor
Salience

* Differences between groups are statistically significant at the p < 0.05
ⱡ Kruskal-Wallis test was utilized to look for significant differences
β Wilcoxon Mann-Whitney test was utilized to look for significant differences
Figure 4. Older individuals rely more on social influence
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*Differences between groups are statistically significant at the p < 0.05
Figure 5. Misconception of men regarding colorectal cancer incidence by gender

*Differences between groups

are statistically significant at the p < 0.05

Figure 6. Misconception of perceived susceptibility in less-educated people
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*Differences between groups are statistically significant at the p < 0.05
Colorectal cancer screening test knowledge and awareness
To compare the knowledge and awareness on colorectal cancer screening tests
with the three independent variables a Chi-Square test of Independence was
conducted. These findings are summarized in Table 8. When patients were asked if they
had heard of a FOBT there were no significant differences between the three age
groups. However, there were significant differences between the three age groups
when they were asked if they ever had FOBT (p < 0.0001), heard of colonoscopy (p =
0.0011), or ever had a colonoscopy (p < 0.0001). 32.6 % of people in the 50 and
above age group have had FOBT while only 3.1 % people in the 30 to 39 age group
and 2.6 % of people in the 40 to 49 group have had FOBT. For the colonoscopy
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questions, more than 73 % of individuals aged 50 and above have heard of
colonoscopy compared to 38.5 % of individuals aged 30 to 39 and 53.8 percent of
individuals aged 40 to 49. For gender there were no significant differences for questions
regarding FOBT or questions regarding colonoscopy. However, it does appear that there
was a higher percentage of females (58.8%) who indicated that they had heard of
colonoscopy compared to 47.1 % of males. When taking into consideration the
education level of participants there were no significant differences for the questions
regarding FOBT. For the questions regarding colonoscopy, there was a significant
difference among the participants for whether they had heard of a colonoscopy (p =
0.0523). More than 41 % of people who had an education of sixth grade or below
reported having heard of colonoscopy compared to 41.5 % of people with an education
level of seventh or eighth grade and 55.6 percent of people with an education level of
high school or above.
Table 8. Knowledge and preferences of CRC screening
tests by age group, gender, and education level
Age group ⱡ
30 to 39 40 to 49
50 and
above
FOBT
n(%)
Heard of FOBT 15(23.1) 8(20.5)
16(34.8)

p-values

0.2537

Ever had FOBT*
Colonoscopy

2(3.1)

1(2.6)

15(32.6)

<0.0001

Heard of colonoscopy*

25(38.5)

21(53.8)

34(73.9)

0.0011

Ever had colonoscopy*

0(0.0)

5(12.8)

14(30.4)

< 0.0001

Gender β
Male
FOBT

Female
n(%)

Heard of FOBT

17(24.3)

22(27.5)

0.7113
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Ever had FOBT

7(10.0)

11(13.8)

0.6162

Heard of colonoscopy

33(47.1)

47(58.8)

0.1899

Ever had colonoscopy

9(12.9)

10(12.5)

1.0000

Colonoscopy

Education level ⱡ
6th
7th – 8th
grade or grade
below
n(%)

FOBT

9th
grade or
above

Heard of FOBT

10(18.9)

11(32.4)

18(28.6)

0.3118

Ever had FOBT

7(13.2)

6(17.6)

5(7.9)

0.3526

Heard of colonoscopy*

22(41.5)

23(67.6)

35(55.6)

0.0523

Ever had colonoscopy

10(18.9)

5(14.7)

19(6.3)

0.1198

Colonoscopy

*Differences between groups are statistically significant at the P < 0.05 level.
ⱡ Chi-square test was utilized to look for significant differences
β Fisher’s exact test was utilized to look for significant differences
FOBT, fecal occult blood test

Discussion
The Latino population included in this study has limited access to some type of
health insurance or coverage. This limited access is one reason for which many
indicated that they do not have someone who they consider their personal doctor.
However, one very interesting finding about this population is that they are still going to
the doctor’s office for a routine check-up. In this study, more than 69 % of the
participants indicated that they had seen a doctor or health professional for a routine
check-up within the last year. Furthermore, almost 70 % of the study participants
indicated that they had seen a provider at least once in the previous year. This finding
is very informative because it indicates that although patients may not have health
insurance or coverage, they are health conscious and hence there are still opportunities
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to have some sort of outreach for these patients regarding colorectal cancer and
colorectal cancer screening.
According to Eshghi et al. (2011), the cumulative colorectal cancer risk is about 5
percent for the entire U.S. population. Furthermore, the CDC estimated that 1.3 percent
of U.S. adults reported being diagnosed with an inflammatory bowel disease, either
Crohn’s disease or ulcerative colitis (CDC, 2017a). Both of these estimates were not
reported by ethnicity, so it is difficult to make comparisons with our study population.
However, it should be noted that in our study population the reported cumulative
colorectal cancer risk was lower at 2.7 percent. Additionally, this study population
reported a much higher percent (5.3%) of having some type of IBD, such as Crohn’s
disease or ulcerative colitis.
When comparing the two tests FOBT and colonoscopy, it appears that more
people have heard of a colonoscopy (53.3%) compared to FOBT (26.0%). This may be
indicative of medical providers recommending colonoscopy more compared to FOBT. It
may also indicate that patients are aware of other tests that may be able to detect
colorectal cancer in the early stages such as fecal immunochemical test (FIT) or a
sigmoidoscopy. One very interesting finding was that patients indicated that they prefer
FOBT compared to a colonoscopy or other test. This could be because FOBT are done
on a yearly basis, and many participants had the false impression that the more often
you do the test the better it is for health. This is one misconception that needs to be
addressed, so that patients are aware that the gold standard for colorectal cancer is
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colonoscopy. Furthermore, only 14.9 percent of patients correctly identified the
screening initiation age.
When we compared individuals that were 50 or older with those that were 30 to
49 we found significant differences for five out of the six questions regarding FOBT and
colonoscopy. We learned that people who were 50 or older were more likely to have
heard of FOBT and/or colonoscopy. Furthermore, they were more likely to have a
doctor advise them to undergo either or both procedures. One final observation was
that people that were 50 or older were more likely to follow through with undergoing
FOBT or colonoscopy. These findings align with the finding reported in Table 5., that
people who are 50 or older are significantly more likely to be aware of the screening
initiation age compared to those in the 30 – 49 age range.
For this study population the mean salience, using the Likert Scale of 1-5, was
4.2. This mean indicates that participants scored slightly above ‘Agree’ to being aware
about the benefits associated with getting screened for colorectal cancer and that this
behavior is encouraged by significant others. The mean score for fear was 2.7, slightly
below ‘Neither Agree nor Disagree’, which indicates that participants do not have
negative perceptions towards undertaking and completing screening for colorectal
cancer. With respect to susceptibility, the mean score was 3.3, slightly above ‘Neither
Agree nor Disagree’, which indicates that these individuals are slightly aware of their
personal risk of developing colorectal cancer or polyps. The mean score for screening
efficacy was 4.1, and this score indicates that people ‘Agreed’ in the value of getting
screened for colorectal cancer. Self-efficacy had a mean score of 3.5, which is in
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between ‘Neither Agree nor Disagree’ and ‘Agree’, and this indicates that individuals are
somewhat aware of the importance of getting screened for colorectal cancer. With
respect to knowledge, the mean score was 3.7, which indicates that this study
population answered slightly below ‘Agree’ about colorectal cancer knowledge. Finally,
for the environmental factor of social influence the mean score was 3.8, and this
indicates that most participants ‘Agree’ that interactions with members of their social
network influences their colorectal cancer screening behavior.
When the study population was divided into three age groups, there was only a
significant difference for the environmental factor of social influence. Individuals in the
age group 30 to 39 had a mean score of 3.6, individuals in the age group 40 to 49 had
a mean score of 3.7, and the 50 or older age group had a mean score of 4.0. This
difference may indicate that the older age group is more likely to be influenced by their
interactions with members of their social network compared to the younger age groups.
As indicated in Figure 4. the older age group selected ‘Agree’ or ‘Strongly Agree’ for the
question ‘Members of my immediate family think I should go through colon cancer
testing.’ This seems to indicate that older people have someone within their social
network that is aware of the increased risk of developing colorectal cancer as an
individual gets older. Furthermore, for the question ‘My doctor or health professional
thinks I should have colon cancer testing’ 82.6 percent of the older age group selected
‘Agree’ or ‘Strongly Agree’. This finding may indicate that the older age group is being
made aware of their need to get screened for colorectal cancer by the provider that
they are seeing. In this graph we can also see that as the age of an individual
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decreases, then it is less likely that a provider will recommend colorectal cancer
screening for them, which is expected.
When the study population was divided into two gender categories, there was a
significant difference for the cognitive factor of knowledge. Males had a mean score of
3.8 and females had a mean score of 3.6. When this difference was further analyzed by
looking at individual questions, there was a significant difference for the question ‘I
believe that colon cancer is mainly a problem for men.’ More than 65 percent of males
agreed or strongly agreed with this statement compared to only 38 percent of females.
This finding may indicate that both males and females are not aware that colorectal
cancer has the ability to affect any individual regardless of gender. However, it is
extremely alarming that such a large proportion of males think that colorectal cancer is
more likely to affect them. One possibility could be that males are confusing colorectal
cancer with prostate cancer. This is definitely an issue that needs to be addressed,
because this could be a potential reason for which individuals are not getting screened
for this type of cancer.
Finally, the study population was broken up into three different groups according
to education level. There was a significant difference between the three different
groups and the cognitive factor of susceptibility. People who were in the education level
group of 6th grade or less had a mean score of 3.6, the 7 th or 8th grade education level
group had a mean score of 3.3, and the 9 th grade or higher group had an education
level of 3.1. Lower education groups think that their personal risk of developing
colorectal cancer or polyps is higher compared to other groups, perhaps reflecting gaps
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in health literacy among individuals with lower education. In the graph titled ‘Perceived
Susceptibility by Education Level’ it can be noted that 86.8 percent of people with an
education level of 6th grade or below were more likely to agree or strongly agree to the
question ‘I believe the chance I might develop colon cancer is high’ compared to 60.3
percent for the high school or above group and 67.6 percent for the seventh or eighth
grade group. In the future analyses we will investigate if people with lower education
level have more difficult time having access to health services or a primary care
provider. If an individual does not see a provider on a regular basis, then it is very likely
that they may not be aware of their health status and will be living in a state of
uncertainty regarding colorectal cancer. For the question ‘I think it is very likely that I
will develop colon cancer’ we see a very similar trend to the previous question. For the
question ‘I believe that the chance that I will develop colon polyps is high we see a
similar trend to the two previous questions. More than 60 percent of people with an
education level of sixth grade or below agreed or strongly agreed compared to 52.9
percent of people with a seventh grade or eighth grade education and 27 percent of
people with a high school education or higher. One common trend among these three
questions is that people with higher education levels are less likely to think that they
will develop colorectal cancer or polyps. With this finding, out next analyses will be to
look at if whether those individuals that reported higher level education also reported
higher income.
One limitation of this study is that it was only delivered to OneWorld patients,
and this excluded individuals of Hispanic or Latino origin that do not seek services at
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One World. These individuals may not have the financial means to seek any type of
medical service or they may be seeking services at another clinic or hospital. Therefore,
the results of this study may underestimate the lack of awareness of CRC and screening
among Latinos. Furthermore, it is very likely that individuals that are not seeking
medical services are less concerned about their health than those that are seeking
medical services. We can expect to find even lower rates of colorectal cancer screening
in the general Hispanic/Latino population that is not seeking out medical services.
Another limitation of this study is that the results cannot be used to analyze
behavior over a longer period. We cannot determine if knowledge, awareness,
perception and attitudes increased after the survey was delivered to these 150
individuals. Furthermore, we will not be able to look at the impact of the colorectal
cancer educational materials that we disseminated to participants at the interview.
Additionally, the timing of this cross-sectional study is not guaranteed to be
representative. The data for this study was collected over the time frame of four
months and the type of patients that receive medical services at One World may vary
seasonally.
Conclusions
In my opinion there are three important conclusions that can be made from this
study. The first is that participants that are 50 years or older were more likely to agree
that they have the social support to undergo colorectal cancer screening tests. This
informs us that by reaching out to the social support system of these individuals we can
also impact those that are due for screening. The second conclusion is that males have
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a misconception that colorectal cancer is more likely to be a problem for men. Finally,
we can conclude that people who have low education are more likely to agree that they
are at a higher risk of developing colorectal cancer. This study enabled the identification
of the current knowledge and awareness, perceptions, attitudes, and barriers to
colorectal cancer screening among the Latino population in Omaha. Furthermore, in the
process of collecting this information participants were educated about colorectal cancer
and the screening tests associated with this type of cancer. Although we are dealing
with a vulnerable population, it is quite clear that this population cares about their
health and is willing to act as long as they have the necessary health education.
Although this study had limitations, it was able to address some very important
questions regarding colorectal cancer. There are two potential interventions that can
help to increase CRC screening rates at OneWorld. The first intervention would be to
make the switch from FOBT to FIT. Patients consider FIT to be a less-invasive test
because it only requires one stool sample as compared to the three stool samples
required by FOBT. Additionally, FIT does not require any diet restrictions, so patients
are more likely to complete this test as compared to FOBT. The second intervention
that I would recommend would be to engage in a FLUFIT or FLUFOBT campaign. The
purpose of this campaign is to help increase screening rates by providing a take home
FOBT or FIT to eligible patients when they receive their annual flu shot.
FLUFIT/FLUFOBT is a research tested program that does not require many resources
and has been proven to be well accepted by patients and lead to higher screening
rates. This program will also allow for an opportunity to identify and reach out to all

Gonzales

43

individuals that are 50 years of age or older. Also, this campaign reinforces the CRC
guidelines that FOBT/FIT must be completed on an annual basis. Future studies should
incorporate a larger sample size and should evaluate why such a large proportion of
males thought that colorectal cancer was mainly a problem for males.

Reflection

Impact of SL/CE at OneWorld
It was a very unique experience being able to conduct my service
learning/capstone experience (SL/CE) at OneWorld. I grew up in South Omaha, and I
am aware of the tremendous impact that OneWorld has had on the health of the South
Omaha community. This community health center provides an inviting environment that
accommodates to the needs of the patients. For example, in the picture below we can
see a ‘paletero’ in the front of the OneWorld building. The simple presence of the
‘paletero’ is welcoming to Latino and Hispanic patients, and sends the message that
they are about to walk into a friendly and understanding environment. Furthermore,
when patients walk inside the building they are greeted with the mission of OneWorld
which is, “OneWorld Community Health Centers, Inc., in partnership with the
community, provide culturally respectful, quality health care with special attention to
the underserved.” In some instances I was able to see the mission of OneWorld being
put into practice. For example, I was able to see the transition of a patient from being
uncomfortable to being comfortable once they learned that their doctor could speak
their native language.
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Many of the patients that seek medical services at OneWorld are from low
socioeconomic status (SES) households, and this makes it difficult for them to find them
affordable health services. However, at OneWorld, health services are delivered to
patients in a much different manner. OneWorld has established a sliding fee scale
system to ensure that health services are a right and not a privilege. Through this
system patients must pay a certain percentage of medical expenses according to gross
monthly income, and this expands on the number of services that can be offered to
patients. Furthermore, OneWorld functions as a prevention oriented clinic in comparison
to hospitals or other private clinics. They are aware that preventing a disease or
diagnosing a disease in the early stages can financially help a patient. This money can
be used by patients to buy food for their household, pay the monthly rent, or buy their
children school supplies.

Colorectal cancer project and service learning at OneWorld
My project consisted of three different activities. The first activity involved
carrying out a study titled ‘Awareness and attitudes of the Latino community in Omaha
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on colorectal cancer and screening.’ This study had two different purposes which were
(1) to investigate the awareness and attitudes of the Latino community in Omaha on
colorectal cancer and screening tests and (2) to identify the barriers that prevent the
Latino community in Omaha from undergoing cancer screening tests, specifically fecal
occult blood test (FOBT) and colonoscopy. This study was possible through the
collaboration of faculty at UNMC, the Nebraska chapter of American Cancer Society, and
OneWorld Community Health Centers. As the picture below shows, I had set up a table
at the lobby of the OneWorld building, and I was recruiting potential participants for the
colorectal cancer study.

The second activity involved identifying the most preferred media outlet for
patients to receive information and education regarding CRC, and identifying the most
effective message to encourage people to get screened for CRC. After delivering the
survey we found that the most preferred media outlet was the community (church,
supermarkets, hospitals, health fairs, community centers) and the most effective
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message was ‘You are so important to your family, don’t let them down! Don’t
procrastinate any longer! Get screened for colon cancer today! It could save your life.’
The third activity involved calling approximately 178 patients that were at least
50 years of age and were due for colorectal cancer screening. When these patients
were called they were educated about the importance of undergoing CRC screening
tests. Furthermore, they were offered three different types of tests which were FOBT,
colonoscopy, or FIT. If a patient agreed to a certain type of screening test then it was
mailed to their household, and a reminder call was given if the patient did not return
the CRC screening test within 10 days. In the picture above, I was identifying OneWorld
patients that were eligible for CRC screening through the electronic health records, and
then called these patients.

Professional Interactions at OneWorld
During this project I was able to interact with individuals from various disciplines.
Some of these disciplines included community navigators, health assistants, nurses, and
physicians. Working at a FQHC was a great experience because I was able to witness
multidisciplinary and interdisciplinary interactions. For example, for my project the
nurse supervisor was able to introduce me to all of the staff, and this facilitated
conducting my project. After I began to know the staff I was able to learn about the
best practices to interact with the patients that seek services at OneWorld. This was
essential due to the nature of my project, and the high likelihood that many participants
would be too shy to complete the survey and provide feedback.

Impact of project
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This project impacted the community and target audience because people
became aware of various things regarding CRC. For example, a large majority of the
patients at OneWorld believed that CRC was predominantly a problem for men. This
misconception could be preventing women from getting screened for this type of
cancer. Also, a large proportion of the OneWorld community believed that getting
screened for CRC every year (FOBT) was better than getting screened for CRC every
ten years (colonoscopy). This finding shows that patients may not be aware of what
tests are more effective at detecting CRC, and this could be a reason why people are
unlikely to get a colonoscopy. Also, providing weekly reminders to patients so that they
could return their FOBT and FIT kits was a very satisfying experience. The more times I
called individuals it appeared that they began to appreciate that I was concerned about
their health. People took the time to explain the various reasons for which they had not
done the screening tests. Some of these reasons included not having the transportation
to get to the clinic, finding the screening test gross, and even not wanting to know if
they had CRC.

Demonstrated competencies
I was able to demonstrate the competencies for epidemiology and social and
behavioral sciences. Through the navigation of the OneWorld electronic health records
(EHR) I was able to identify principles and limitations of the CRC screening program.
For example, staff were giving patients FOBT kits but were not following up with
patients to ask them if they had a positive or negative test result. This was mainly due
to the lack of communication between the staff lab at OneWorld that examines the
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FOBT kits and the health assistants, nurses, and other providers who have to update
the EHRs. For the social and behavior sciences, I was able to identify the causes of
social and behavioral factors that affect health of individuals and populations. For
example, a large majority of patients at OneWorld were not aware of the appropriate
age to begin screening for CRC. Additionally, patients thought that CRC was
predominantly a problem for men. I was able to demonstrate communication and
informatics by being able to switch my communication styles for when I was
communicating with patients and when I was communicating with OneWorld staff. This
was important for engaging the patients because the majority of OneWorld patients
have an educational level that is below high school, and this affects the health literacy
of the patients. Finally, I demonstrated leadership by engaging in dialogue and learning
from others in order to advance public health goals. This was primarily done through
interactions with individuals in the Colorectal Cancer Task Force that was initiated by
OneWorld. During meetings we would discuss the CRC screening rates and what we
could do to increase these rates.
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Appendix A: Likert graphs for questions regarding barriers to colorectal
cancer and colorectal cancer screening .
The questions in these graphs were asked through a five-point version of the Likert
Scale, which allowed respondents to indicate if they Strongly Agree, Agree, Neither
Agree nor Disagree, Disagree, or Strongly Disagree with a question. We scored the
five-point Likert Scale by assigning a value of 5 for Strongly Agree, a value of 4 for
Agree, a value of 3 for Neither Agree nor Disagree, a value of 2 for Disagree, and a
value of 1 for Strongly Disagree. In these graphs we grouped together the responses
‘Agree’ and ‘Strongly Agree’ and reported them as percentages on the left side of the
graphs. We also grouped together the responses ‘Disagree’ and ‘Strongly Disagree’ and
reported them as percentages on the right side of the graphs. The response ‘Neither
Agree nor Disagree’ was not grouped with any other response, and the percentage for
this response is not reported in the graphs.
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Appendix B: Colorectal cancer survey in English.

Date:

Survey #:

Colorectal Cancer Survey: Awareness and Attitudes of the Latino Community in
Omaha on Colorectal Cancer and Screening Tests (IRB # 303-17-EX)
This research study is being conducted by the University of Nebraska Medical Center
College of Public Health and One World Community Health Centers as part of an effort
to: (1) To investigate the awareness and attitudes of the Latino community in Omaha on
colorectal cancer and screening tests and (2) To identify the barriers that prevent the
Latino community in Omaha from undergoing colorectal cancer screening tests,
specifically fecal occult blood test and colonoscopy.

To participate in this study, you must be at least 30 years old and be of Latino or
Hispanic origin.
There is a total of 60 questions on this survey divided into 5 sections including:
Demographics, Medical History, Knowledge and Awareness on Colorectal Cancer and
Screening Tests, Perception and Attitudes on Colorectal Cancer and Screening Tests, and
Barriers on Colorectal Cancer Screening.
The survey will take approximately 15 to 20 minutes to complete and you will be
compensated for your time after your completion of this survey.
Your participation in this survey is completely voluntary. You may decline to participate,
stop at any point during the survey, or skip any question you don’t wish to answer. Your
responses will remain confidential and anonymous. If you have any questions or
concerns about the research study please feel free to contact any of the study personnel
listed below.
Study team
Roger Gonzales
(402)578-9155
roger.gonzales@unmc.edu

Dr. Evi Farazi
(402)559-5907
evi.farazi@unmc.edu

Dr. Armando De Alba Rosales
(402)559-3835
armando.dealba@unmc.edu

Dr. Lynette Smith
(402)559-8114
lmsmith@unmc.edu
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Dr. Hongmei Wang
(402)559-9413
hongmeiwang@unmc.edu

Dr. Jungyoon Kim
(402)552-7235
jungyoon.kim@unmc.ed
Colorectal Cancer Questionnaire:

“Awareness and attitudes of the Latino community in Omaha on colorectal cancer and
screening tests”
Demographic Questions
1. What is your age? ___________

(code age in years)
 Male

2. What is your gender?

I’m not sure/I don’t know
 Female

Other: __________
Yes

3. Are you Latino, Hispanic, or Spanish origin?
3a. If “Yes”, ask: Are you…?
 Mexican, Mexican American, or Chicano
 Puerto Rican
 Cuban
 Central American
 South American
 Another Latino, Hispanic, or Spanish origin

4. On a scale from zero to ten, please indicate your level of proficiency in speaking,
understanding, and reading in the English language:
Speaking

Understand
spoken
language

5. Are you… ?
 Married
 Divorced Widowed
 A member of an unmarried couple

Separated

Reading

Never married

6. What is the highest grade or year of school you completed?
 Never attended school or only received preschool education
 Grades 1 through 6 (Elementary)
 Grades 7 through 8 (Middle school)
 Grades 9 through 12 or diploma equivalent to baccalaureate (High school)
 University or bachelor’s degree
 Postgraduate university studies

No
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7. Is your annual household income from all sources…?
 Less than $25,000 (if no go to $35,000)
 Less than $20,000
 Less than $15,000
 Less than $10,000
 Less than $35,000 (go here)
 Less than $50,000
 Less than $75,000
 $75,000 or more

Medical History
8. Would you say that in general your health is:
 Excellent  Very Good
 Good  Fair

 Poor

9. Currently, do you have some type of health care coverage?

 Don’t know/Not sure
 Yes

 No

9a. If “Yes”, ask: Do you have …?
 Private insurance
 Public health insurance (Medicare or Medicaid)
 Other type of health insurance: __________
9b. If “No”, ask: About how long has it been since you last had health care coverage?
 6 months or less
 More than 6 months, but not more than 1 year ago
 More than 1 year, but not more than 3 years ago
 More than 3 years
 Never
 Don’t know/Not sure
10. Do you have one person you think of as your personal doctor of health care provider?
10a. If “No,” ask: “Is there more than one, or is there no person who you think of as
your personal doctor or health care provider?”
 Yes, only one
 More than one
 No
 Don’t know/Not sure
11. Was there a time in the past 12 months when you needed to see a doctor but could not
because of cost?
 Yes
 No
 Don’t know/Not sure
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12. About how long has it been since you last visited a doctor for a routine checkup? A routine
checkup is a general physical exam, not an exam for a specific injury, illness, or condition.
 Within the past year (anytime less than 12 months ago)
 Within the past 2 years (1 year but less than 2 years ago)
 Within the past 5 years (2 years but less than 5 years ago)
 5 or more years ago
 Don’t know/Not sure
 Never
13. In the last 12 months, not counting times you went to an emergency room, how many times
did you go to a doctor, nurse, or other health professional to get care for yourself?
 1 time
 2 times
 3 times
 4 times
 5-9 times
 10 or more times  None
 Don’t know/Not sure
14. Has a doctor ever detected colon cancer or any polyps in your colon?
 Yes
 No
 Don’t know/Not sure
15. Has a doctor ever diagnosed you with an inflammatory bowel disease such as Crohn’s disease
or ulcerative colitis?
 Yes
 No
 Don’t know/Not sure
16. Have any of your family members ever been diagnosed with colon cancer or had polyps in
their colon?
 Yes
 No
 Don’t know/Not sure
16a. If the response is yes, was this family member a first-degree relative (parent, sibling, or child)
or not a first degree relative (aunts, uncles, cousins)?
 First-degree relative

 Not a first-degree relative

 Don’t know/Not sure

Knowledge and Awareness on Colorectal Cancer and Screening Tests
The next questions are about tests for colon cancer. There are different kinds of tests for
colorectal cancer. The first questions are about the fecal occult blood test (FOBT) for
colorectal cancer.
FOBT. A fecal occult blood test or stool blood test is a test to check for colorectal cancer. It is
done at home using a set of 3 cards. You smear a sample of your fecal matter or stool on a card
from 3 distinct bowel movements and return the cards to be tested for the presence of blood.
17. Before this test was described, had you ever heard
of a fecal occult or stool blood test?

 Yes
 No
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 Don’t know/Not sure
18. In the last 12 months, did a doctor, nurse, or other
health professional advise you to do a stool blood test
using a “home” test kit?

 Yes
 No
 Don’t know/Not sure

19. Have you ever done a stool blood test using a “home”
test kit?

 Yes [Go to question 20]
 No [Go to question 23]
 Don’t know/Not sure
[Go to question 23]

20. How many home stool blood tests have you done in
the last 5 years?

0
1
2
3
4
5
 5 or more
 Don’t know/Not sure

21. When was your most recent home stool blood
test?

 A year ago or less
 More than 1 but not
more than 2 years ago
 More than 2 but not
more than 5 years ago
 More than 5 years ago
 Don’t know/Not sure

22. Why did you do your most recent home stool blood test?

 Part of a routine exam or
check-up
 Because of a symptom or
health problem
 Follow-up of an earlier
abnormal test
 Don’t know/Not sure

The next questions are about colonoscopy. Colonoscopy is a test that uses a narrow, lighted
tube to examine the entire colon. With a colonoscopy, you are given medicine through a needle
in your arm to make you sleepy, you need someone to drive you home, and you may need to
take the rest of the day off from normal activities.
23. Before this test was described, had you ever heard of
colonoscopy?

 Yes
 No
 Don’t know/Not sure
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24. In the last 12 months, did a doctor, nurse, or other health
professional advise you to get a colonoscopy?

Yes
No
 Don’t know/Not sure

25. Have you ever had a colonoscopy?

 Yes [Go to question 26]
 No [Go to question 29]
 Don’t know/Not sure
[Go to question 29]

26. How many colonoscopy exams have you had in the last
10 years?

0
1
2
 More than 2
 Don’t know/Not sure

27. When was your most recent colonoscopy?

 A year ago or less
 More than 1 but not
more than 5 years ago
 More than 5 but not
more than 10 years ago
 More than 10 years ago
 Don’t know/Not sure

28. Why did you do your most recent colonoscopy?

 Part of a routine exam or
check-up
 Because of a symptom or
health problem
 Follow-up of an earlier
abnormal test
 Don’t know/Not sure

Perceptions and Attitudes on Colorectal Cancer and Screening Tests
The next questions ask what you think about colon cancer tests.
29. Which colon cancer screening test would you most want
to use if your doctor recommended you be tested for
colon cancer

 FOBT (fecal occult
test/stool blood test)
 Colonoscopy
 Other test:__________
 I would not want to be
tested

Gonzales

75

 Don’t know/Not sure
30. Which statement is closest to where you are now
in your plans to get tested for colon cancer?

 I am not thinking of getting
tested for colon cancer
 I think I need to consider
getting tested for colon cancer
 I think I should get tested for
colon cancer, but I am not
ready
 I think I will probably get
tested for colon cancer
 I am committed to getting
tested for colon cancer

31. What is the reason for your response if your
response was not ‘I am committed to getting tested
for colon cancer’?

 I do not have health
insurance
 I would rather not know if
I have colon cancer
 I think that the screening
tests for colon cancer are
disgusting or uncomfortable
 I do not have any symptoms
of colon cancer
 I need more information
about the screening tests
 I do not have time
 Other: ________________
________________________

32. At what age are people supposed to start getting
tested for colon cancer?
(your best guess is fine)

_______________________

33. In general, once people start doing “home” stool blood
tests for colon cancer, about how often should they
should do them? (your best guess is fine)

34. In general, once people start colonoscopy exams, about
how often should they have them? (your best
guess is fine)

 Once a year
 Every 5 years
 Every 10 years
 Only when there is a
problem
 Other (specify)
_______________________
 Once a year
 Every 5 years
 Every 10 years
 Only when there is a
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problem
 Other (specify): ________

Barriers on Colorectal Cancer Screening
The next questions ask for your opinions about colon cancer and colon cancer testing. For
each statement below, check whether you strongly agree, agree, neither agree nor disagree,
disagree, or strongly disagree.
Neither
Strongly
Agree Nor
Strongly
Agree
Agree
Disagree
Disagree Disagree
35. I believe the chance I might develop colon
cancer is high.











36. Doing colon cancer testing makes sense to
me.































39. I want to do what members of my
immediate family think I should do about
colon cancer.











40. Going through colon cancer testing is an
important thing for me to do.











41. I believe that having colon cancer testing can
help to protect my health.











37. Arranging my schedule to go through colon
cancer testing is an easy thing to do.

38. I think the benefits of colon cancer testing
outweigh any difficulty I might have in doing
the tests.

Agree

Neither
Agree Nor
Disagree

Disagree

Strongly
77
Disagree











43. I intend to undergo colon cancer testing.











44. I am afraid of having an abnormal test
result.











45. I think it is very likely that I will develop
colon cancer.











46. I think that when colon polyps are found
and removed, colon cancer can be
prevented.











47. Going through colon cancer testing would
be difficult for me to do.











48. Members of my immediate family think I
should go through colon cancer testing.











49. I am worried that testing will show that I
have colon cancer.











50. I believe that the chance that I will develop
colon polyps is high.











51. I am bothered by the possibility that testing
might be physically uncomfortable.











52. I believe that when colon cancer is found
early, it can be cured.











Strongly
Agree

42. Finding time to go through colon cancer
testing would be difficult for me to do.
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Neither
Agree Nor
Disagree

Disagree

Strongly
78
Disagree











54. I think that compared to other persons
my age, I am at lower risk for colon cancer.











55. My doctor or health professional thinks I
should have colon cancer testing.











56. I want to do what my doctor or health
professional thinks I should do about colon
cancer testing.











57. I believe that colon cancer is mainly a
problem for men.











58. I believe that a person could have colon
cancer but not have any symptoms.











59. I think that getting checked regularly for
colon cancer increases the chances of
finding cancer when it’s easy to treat.











60. People should learn about colon cancer
tests in their 20s and 30s.











Strongly
Agree

53. I think that going through colon cancer
testing would be an easy thing for me to
do.
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Which media outlet you would most prefer, so that you can receive colorectal cancer screening
education and reminders? Rank the following items from 1 to 9, with 1 being the highest preference and
9 being the lowest preference.
Media outlet
Television (Univision and Telemundo, sports, novelas, medical shows, news)

Rank

Internet (Facebook, Instagram, twitter, search engine, news feed)
Community (churches, supermarkets, hospitals, health fairs, community centers)
Text messaging
Radio (97.7 radio Lobo, 102.3 El Patron)
Newspaper (El Perico, Omaha World Herald)
Photo novela
Brochures
Postcards through mail
Which message do you think would be the most effective to get members of the Latino community to
undergo colorectal cancer screening? Rank the following messages from 1 to 6, with 1 being the most
effective message and 6 being the least effective message.
Message
If you are 50 or older, you’re at a higher risk for colon cancer—even if you are
healthy. Ask your doctor for a screening test. You can do a simple test at home.
Colon cancer starts with a polyp in the large intestine. Polyps are very common in
people age 50 and older, but they can be detected and removed before they turn
into cancer. Don’t die of cancer. Talk to your doctor about colon cancer
prevention.
You are so important to your family, don’t let them down! Don’t procrastinate
any longer! Get screened for colon cancer today! It could save your life.
Colon cancer is the second leading cancer killer in the U.S. among Hispanics, but it
doesn’t have to be. Colon cancer can be prevented or found at an early stage.
Getting screened is absolutely necessary! Call a doctor today.
Hi, my name is Maria. I lost my father to colon cancer. He was too stubborn to
get screened, but the cancer might have been prevented if he did. Don’t let your
family lose you too. Get screened and prevent colon cancer.
Colon cancer is a silent killer! Many people with colon cancer do not have any
symptoms or a family history. This is why screening is necessary even when you
feel healthy. Don’t wait until you have symptoms.

Rank
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Appendix C: Colorectal cancer survey in Spanish.
Fecha:
Cuestionario #:
Cuestionario de Cáncer Colorrectal: Conocimiento y Actitudes de la Comunidad
Latina en Omaha acerca del Cáncer Colorrectal y sus Pruebas Diagnósticas (IRB #
303 – 17 – EX)
Este estudio está siendo realizado por el Centro Médico de la Universidad de Nebraska, Colegio
de Salud Pública y One World Centro de Salud Comunitario como parte de un esfuerzo para: (1)
investigar la conciencia y las actitudes de la comunidad Latina en Omaha sobre el cáncer
colorrectal y sus pruebas diagnósticas y (2) identificar las limitaciones que impiden que la
comunidad Latina de Omaha se someta a exámenes de detección de cáncer colorrectal,
específicamente análisis de sangre oculta en heces y colonoscopia.

Para participar en el estudio, usted tiene que tener por lo menos 30 años y ser
de origen Latino o Hispano.
Hay un total de 60 preguntas en esta encuesta divididas en 5 secciones incluyendo:
Demografías, Historial Médico, Conocimiento y Entendimiento del Cáncer Colorrectal y
sus Pruebas Diagnósticas, Percepciones y Actitudes Relacionadas al Cáncer Colorrectal y los
Exámenes de Detección, y Limitaciones Para la Realización de Exámenes de Detección de
Cáncer Colorrectal.
La encuesta tomará aproximadamente 15 a 20 minutos para completar y usted será
recompensado por su tiempo después de completar esta encuesta.
Su participación en esta encuesta es completamente voluntaria. Puede negarse a participar,
declinar por completo, detenerse en cualquier momento durante la encuesta u omitir cualquier
pregunta que no desee responder. Sus respuestas serán confidenciales y anónimas. Si tiene
alguna pregunta o inquietud sobre el estudio, no dude en comunicarlo a cualquier persona del
estudio listada abajo.

Equipo de Investigación
Roger Gonzales
(402)578-9155
roger.gonzales@unmc.edu

Dr. Evi Farazi
(402)559-5907
evi.farazi@unmc.edu

Dr. Armando De Alba Rosales
(402)559-3835
armando.dealba@unmc.edu

Dr. Lynette Smith
(402)559-8114
lmsmith@unmc.edu

Dr. Hongmei Wang
(402)559-9413
hongmeiwang@unmc.edu

Dr. Jungyoon Kim
(402)552-7235
jungyoon.kim@unmc.edu
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Cuestionario de Cáncer Colorrectal:
“Conocimiento y Actitudes de la Comunidad Latina en Omaha acerca del Cáncer
Colorrectal y sus Pruebas Diagnósticas”
Preguntas demográficas
1. ¿Qué edad tiene? ___________ (Codifique la edad en años)
 Masculino

2. ¿Cuál es su género?

 No sabe/No está seguro /a

 Femenino  Otro: ___________
 Sí

3. ¿Es usted Latino /a, Hispano /a, o de origen Español?

No

3a. Si la respuesta es “Si” pregunte: ¿Es usted…?







Mexicano/a, Mexicano-American/a, o Chicano/a
Puertorriqueño/a
Cubano/a
Centroamericano/a
Sudamericano/a
De otro origen Latino, Hispano, o Español

4. En una escala de cero a diez, por favor indique su nivel de habilidad para hablar, entender y
leer en el idioma inglés:
Hablar

Entender
lenguaje
hablado

5. ¿Es usted…?
 Casado /a
 Divorciado /a
Nunca estuvo casado /a

Leer

 Viudo/a
 Separado /a
 Vive en pareja sin estar casado /a

6. ¿Cuál es el grado más alto o año de la escuela que completó?
 Nunca fue a la escuela o solo recibió educación preescolar
 De 1° a 6° grado (educación primaria)
 De 7° a 8°grado (educación secundaria)
 De 9° a 12° grado o diploma equivalente a Bachillerato (Preparatoria)
 Universidad o Licenciatura
 Estudios de postgrado universitario
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7. Tomando en cuenta todas sus fuentes de ingresos, los ingresos anuales de su hogar son:
 Menos de 25,000 dólares (Si la respuesta es “No”, pregunte “Menos de 35,000 dólares”)
 Menos de 20,000 dólares
 Menos de 15,000 dólares
 Menos de 10,000 dólares
 Menos de 35,000 dólares (aquí)
 Menos de 50,000 dólares
 Menos de 75,000 dólares
 75,000 dólares o más

Historial médico
8. ¿Diría usted que su estado de salud general es…?:
 Excelente  Muy Bueno  Bueno  Regular

 Malo

 No sabe/No está seguro/a

9. Actualmente, ¿tiene algún tipo de seguro o cobertura de gastos médicos?

 Sí

No

9a. Si la respuesta es “Si” pregunte: ¿Es este seguro…?
 Privado
 Público (Medicare, Medicaid)
 Otra cobertura: __________________________
9b. Si la respuesta es “No” pregunte: ¿Cuánto hace que no tiene seguro de gastos médicos?
 Hace 6 meses o menos
 Hace más de 6 meses, pero menos de 1 ano
 Hace más de 1 ano, pero menos de 3 anos
 Hace más de 3 anos
 Nunca
 No sabe/No está seguro /a
10. ¿Hay alguna persona a la que usted considere su médico de cabecera o proveedor de atención
medica personal?
 Sí, solo uno
 Más de uno
 No
 No sabe/No está seguro /a
11. En los últimos 12 meses, ¿hubo algún momento en que necesitó ver a un médico, pero no
pudo hacerlo por razones económicas?
 Sí
 No
 No sabe/No está seguro /a
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12. ¿Aproximadamente, cuándo fue la última vez que fue al médico para hacerse un
chequeo de rutina? Un chequeo de rutina es un examen físico general, que no se realiza
por una lesión, enfermedad o afección específica.
 En el último año (hace menos de 12 meses)
 En los últimos 2 años (hace 1 año, pero menos de 2)
 En los últimos 5 años (hace 2 años per menos de 5)
 Hace 5 años o mas
 Nunca
 No sabe/No está seguro /a
13. En los últimos 12 meses, sin contar las veces que fue a una sala de emergencias, ¿cuántas
veces fue a un médico, enfermera u otro profesional de la salud para recibir atención médica?
 1 vez
 2 veces
 3 veces
 4 veces
 5-9 veces
 Nada
 No sabe/No está seguro/a
14. ¿Alguna vez algún médico le ha detectado cáncer de colon o algún pólipo (adenomatoso) en
su intestino?
 Sí
 No
 No sabe/No está seguro/a
15. ¿Alguna vez algún médico le ha diagnosticado que tiene una enfermedad intestinal
inflamatoria como enfermedad de Crohn o colitis ulcerosos?
 Sí
 No
 No sabe/No está seguro/a
16. ¿Alguna vez le han diagnosticado a un familiar de usted cáncer de colon o algún pólipo en su
intestino?
 Sí
 No
 No sabe/No está seguro/a
16a. Si la respuesta fue sí, ¿fue esta persona un familiar directo (padres, hermanos, hijos) o un
familiar lejano (tíos, primos)?
 Familiar directo

 Familiar lejano

 No sabe/No está seguro/a

Conocimiento y Entendimiento del Cáncer Colorrectal y sus Pruebas Diagnosticas
Las siguientes preguntas están relacionadas a las pruebas para diagnosticar el cáncer de
colon. Existen diferentes tipos de exámenes para detectar el cáncer de colon. Las primeras
preguntas son acerca del examen de sangre oculta en heces
El examen de sangre oculta en heces es un estudio que se realiza para detectar la presencia de
sangre mezclada en la materia fecal o excremento. En casa, el paciente coloca una muestra
pequeña de materia fecal en un tubo recolector especial o en tarjetas especiales (tres tarjetas).
En el caso de las tarjetas especiales, se toman muestras de tres evacuaciones distintas y se
envían de regreso al doctor o al laboratorio para su análisis.
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17. Antes de que le describiera este examen, ¿alguna vez
había usted escuchado de algún examen de sangre
oculta en heces?

 Sí
 No
 No sabe/No está seguro /a

18. ¿En los últimos 12 meses, algún médico, enfermero u
otro profesional de la salud le ha aconsejado que se haga
un examen de sangre oculta en heces usando un paquete/
instrumentos para tomar la prueba en casa?

 Sí
 No
 No sabe/No está seguro /a

19. ¿Alguna vez se ha hecho un examen de sangre oculta en
heces usando un paquete/instrumentos para tomar la
prueba en casa?

 Sí [Ir a la pregunta 20]
 No [Ir a la pregunta 23]
 No sabe/No está seguro /a
[Ir a la pregunta 23]

20. Usando la prueba casera, ¿Cuántos exámenes de sangre
oculta en heces se ha hecho en los últimos 5 años?

0
1
2
3
4
5
 5 o más
 No sabe/No está seguro /a

21. Usando la prueba casera ¿Cuándo fue su examen mas
reciente de sangre oculta en heces?

 Hace un año o menos
 Más de 1 pero no más de
2 años atrás
 Más de 2 pero no más de
5 años atrás
 Hace más de 5 años
 No sabe/No está seguro/a

22. ¿Cuál es la razón por la cual se hizo su examen mas
reciente de sangre oculta en heces?

 Parte de un examen de
rutina o revisión
 Debido a un síntoma o
problema de salud
 Seguimiento de una
prueba anormal anterior
 No sabe/No está
seguro /a
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Las siguientes preguntas son en relación al examen de colonoscopía. La colonoscopía es un
procedimiento que utiliza un tubo largo, flexible y delgado, con una luz y una pequeña cámara
en un extremo para ver el interior del recto y todo el colon. Cuando se hace una colonoscopía,
al paciente se le administra medicamento inyectado en la vena para que le de sueño. El
paciente necesita que alguien lo lleve a su casa, y quizás necesite tomar el resto del día libre de
sus actividades normales.
23. Antes de que le describiera este examen, ¿alguna vez
había usted escuchado del examen de la colonoscopía?

 Sí
 No
 No sabe/No está seguro /a

24. En los últimos 12 meses, ¿algún médico, enfermero
u otro profesional de la salud le ha aconsejado que
se haga una colonoscopía?

 Sí
No
No sabe/No está seguro /a

25. ¿Alguna vez se ha realizado una colonoscopía?

 Sí [Ir a la pregunta 26]
 No [Ir a la pregunta 29]
 No sabe/No está seguro /a
[Ir a la pregunta 29]

26. ¿Cuántos exámenes de colonoscopía se ha hecho
en los últimos 10 años?

0
1
2
 Más de 2
 No sabe/No está seguro/a

27. ¿Cuándo fue su colonoscopía más reciente?

 Hace un año o menos
 Más de 1 pero no más
de 5 años atrás
 Más de 5 pero no más de
10 años atrás
 Hace más de 10 años
 No sabe/No está seguro /a

28. ¿Cuál es la razón por la cual se realizó su colonoscopía
más reciente?

 Parte de un examen de
un examen de rutin a o
chequeo
 Debido a un síntoma o
problema de salud
 Seguimiento de una
prueba anormal anterior
 No sabe/No está
seguro /a
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Percepciones y Actitudes Relacionadas al Cáncer Colorrectal y los Exámenes de Detección
Las siguientes preguntas son relacionadas a lo que usted piensa de los exámenes para
diagnosticar el cáncer de colon.
29. ¿Qué examen diagnostico preferiría usted si su médico
le recomendara hacerse una prueba para detectar el
cáncer de colon?

 SOH (examen de sangre
oculta en heces)
 Colonoscopia
 Otro examen: _________
 No quisiera ser
examinado
 No sabe/No está seguro /a

30. ¿Cuál de las siguientes afirmaciones refleja
de mejor manera sus planes para realizarse
un examen de diagnóstico de cáncer de
colon?

 No estoy pensando en hacerme el
examen de cáncer de colon
 Creo que debo considerar hacerme
el examen de cáncer de colon
 Creo que debería hacerme el examen de
cáncer de colon, pero no estoy listo
 Creo que probablemente me hare el
examen de cáncer de colon
 Estoy decidido(a) a hacerme el
examen de diagnóstico de cáncer de
colon

31. Si su respuesta no fue: “Estoy decidido(a)
a hacerme el examen de cáncer de colon”,
¿cuál fue la razón?

 No tengo seguro de salud
 Prefiero no saber si tengo cáncer de colon
 Creo que los exámenes de detección de
cáncer de colon son asquerosas y/o
incomodos
 No tengo ningún síntoma de cáncer de
colon
 Necesito más información sobre los
exámenes de detección de cáncer de
colon
 No tengo tiempo
 Otra: _____________________________
______________________________

32. ¿A qué edad considera que las personas deben
comenzar a hacerse un examen para detectar el
cáncer de colon?
(cualquier intento de adivinar es bienvenido)

______________________________
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33. Una vez que las personas comienzan a hacerse los exámenes
de sangre oculta en heces para detectar el cáncer de colon,
¿con qué frecuencia creé usted que estas personas tengan
que volver a hacerse este examen?
(cualquier intento de adivinar es bienvenido)

 Una vez al año
 Cada 5 años
 Cada 10 años
 Solo cuando hay un
problema
 Otra (especificar)
_______________________

34. Una vez que las personas comienzan a hacerse los exámenes
de colonoscopia, ¿con qué frecuencia creé usted que estas
personas tengan que volver a hacerse este examen?
(cualquier intento de adivinar es bienvenido)

 Una vez al año
 Cada 5 años
 Cada 10 años
 Solo cuando hay un
problema
 Otra (especificar)
_______________________

Limitaciones Para la Realizacion de Examenes de Detección de Cáncer Colorrectal 88
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Las siguientes preguntas piden sus opiniones sobre cáncer de colon y examines de cáncer de colon. Para cada
declaración marque si está en muy de acuerdo, de acuerdo, ni de acuerdo ni en desacuerdo, en desacuerdo, o muy en
desacuerdo.
Ni de Acuerdo
Muy
De
ni en
En
Muy en
de Acuerdo Acuerdo
Desacuerdo
Desacuerdo Desacuerdo
35. La posibilidad de que desarrolle
cáncer de colon es alta.











36. Comprendo la importancia de
realizarme pruebas de detección de
cáncer de colon











37. Puedo organizar fácilmente mí tiempo
para realizarme un examen de
diagnóstico de cáncer de colon.











38. Al hacerme el examen de diagnóstico
de cáncer de colon, creo que los
beneficios son mayores que los riesgos.











39. Quiero seguir las recomendaciones que
los miembros cercanos de mi familia
me dan acerca del cáncer de colon.











40. Es importante para mi realizarme el
examen de diagnóstico de cáncer de
colon.





















41. Creo que realizarme el examen
diagnóstico de cáncer de colon puede
ayudar a proteger mi salud.
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42. Es difícil para mí organizar mi tiempo para
realizarme un examen de diagnóstico de
cáncer de colon.











43. Tengo la intención de someterme a
un examen de diagnóstico de cáncer de
colon.











44. Tengo miedo de que el resultado de mi
examen de diagnóstico no sea normal.











45. Creo que es muy probable que desarrolle
cáncer de colon.











46. Considero que cuando hay pólipos en el
colon y estos se extirpan, el cáncer de
colon se puede prevenir.











47. Sería difícil para mí realizarme un examen
de diagnóstico de cáncer de colon.











48. Los miembros cercanos de mi familia
piensan que debo realizarme el examen de
diagnóstico de cáncer de colon.











49. Me preocupa que el examen de
diagnóstico demuestre que tengo cáncer
de colon.











50. Creo que la probabilidad de que desarrolle
pólipos en el colon es alta.





















51. Me molesta la posibilidad de que el
examen de diagnóstico de cáncer de colon
sea físicamente incomodos.
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52. Creo que cuando el cáncer de colon es

diagnosticado en una etapa temprana, es
curable.









53. Es fácil para mi realizarme un examen de
diagnóstico de cáncer de colon.











54. Creo que en comparación con otras
personas de mi edad, tengo un menor
riesgo de padecer cáncer de colon.











55. Mi médico o proveedor de salud
considera que debería someterme a un
examen de diagnóstico de cáncer de
colon.











56. Quiero seguir las recomendaciones que
mi médico o proveedor de salud me dan
para detectar el cáncer de colon.











57. Creo que el cáncer de colon es
principalmente un problema para los
hombres.











58. Creo que una persona podría padecer
cáncer de colon, sin presentar ningún
síntoma.































59. Considero que realizarse chequeos
regulares aumenta la posibilidad de
diagnosticar el cáncer de colon en
etapas en las que fácilmente se pueda
tratar.

60. La gente que está en sus años 20 y 30
debería conocer acerca de los exámenes
de diagnóstico de cáncer de colon.
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¿Qué medio de comunicación prefiere para recibir educación y avisos sobre la detección de cáncer
colorrectal? Clasifique los siguientes medios de comunicación del 1 al 9. Use el 1 para el medio de
comunicación que más prefiere y el 9 para el medio de comunicación que menos prefiere.
Medio de comunicacion
Televisión (Univision y Telemundo, deportes, novelas, programas médicos, noticias)
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Internet (Facebook, Instagram, Twitter, noticias)
Comunidad (iglesias, supermercados, hospitales, ferias de salud, centros comunitarios)
Mensaje de texto
Radio (97.7 radio Lobo, 102.3 El Patron)
Periodico (El Perico, Omaha World Herald)
Fotonovela
Folletos
Tarjeta postal a través del correo
¿Qué mensaje cree usted que sería más efectivo para que los miembros de la comunidad Latino se
sometan a un examen de detección de cáncer colorrectal? Clasifique los siguientes mensajes del 1 al 6.
Use el 1 para el mensaje que sería más efectivo y el 6 para el mensaje que sería menos efectivo.
Mensaje
Si tienes 50 años o más, estás en un mayor riesgo del cáncer de colon, incluso si te sientes
saludable. Pide a tu médico una prueba de detección. Puedes hacer una prueba simple en
tu casa.
El cáncer de colon comienza con un pólipo en el intestino grueso. Los pólipos son muy
comunes en las personas mayores de 50 años, pero pueden ser detectados y eliminados
antes de que se conviertan en cáncer. No muera de cáncer. Hable con su médico sobre la
prevención del cáncer de colon
Tú eres muy importante para tu familia, ¡no los defraudes! ¡Ya no demores esto! ¡Hazte
un examen de detección de cáncer de colon hoy mismo! Puede salvar tu vida.
El cáncer de colon es la segunda causa de fallecimientos por cáncer entre los hispanos de
EE. UU., ¡pero es algo que se puede evitar! El cáncer de colon se puede prevenir o
detectar en sus etapas tempranas. ¡Es absolutamente necesario que te hagas un examen
de detección! Llama al médico hoy mismo.
Hola, me llamo María. Perdí a mi padre a causa del cáncer de colon. Él era demasiado
testarudo para hacerse una prueba de detección, pero el cáncer pudo haber sido
prevenido si lo hubiese hecho. No dejes que tu familia también te pierda. Hazte una
prueba de detección y previene el cáncer de colon.
¡El cáncer del colon es un asesino silencioso! Muchas personas con cáncer del colon no
presentan ningún síntoma ni tienen antecedentes en su familia. Por esto los exámenes de
detección son necesarios aunque pienses que estás sano. No esperes hasta que tengas
síntomas.
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